Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Фільтри

(Clear all)

HOME-based ICT solutions FOR the independent living of people with DEMentia and their caregivers

Home4Dem

The overall objective of Home4Dem is to address the challenge of dementia care that is a major burden for industrialised societies, through the large-scale deployment in the market of an innovative ICT platform to enable people with dementia to live at home independently and to maintain an active social life, thus improving their quality of life...

Funding Programme
Start Date
End Date
Total Funding
€ 3 352 100
European Countries Involved

How the brain creates Mutual Understanding during Social InteraCtion

MUSIC

How can we understand one another? Our everyday conversations appear to revolve around our linguistic abilities. But creating mutual understanding involves more than formulating grammatically correct sentences. Recently, cognitive science has shown that mutual understanding relies on shared knowledge and beliefs, conceptual knowledge that is...

Funding Programme
Start Date
End Date
Total Funding
€ 260 930
European Countries Involved

How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model

RECAGE

The RECAGE project will tackle one of the most challenging problem arising during the clinical course of dementia: the so-called Behavioural and Psychological Symptoms of Dementia (BPSD). The current state-of-the-art of the treatment of these symptoms is still unsatisfactory and there are many unmet needs in this area. The major objective of the...

Funding Programme
Start Date
End Date
Total Funding
€ 2 824 038
European Countries Involved

Hyper-emotionality after neurodegenerative loss of inhibition of the amygdala

URBACH-ALZ

I propose to test how hyper-anxiety in Alzheimer's disease (AD) patients is caused by neurodegeneration in the amygdala, our 'center of fear', by comparing with a unique group of Urbach Wiethe disease (UWD) patients with bilateral neurodegeneration of the amygdala (BLA) for which I also construct an animal model. UWD is caused by a very rare...

Funding Programme
Start Date
End Date
Total Funding
€ 173 634
European Countries Involved

ICT services for Life Improvement For the Elderly

ICT4Life

There are many efforts at European level to improve our ability to monitor health and to prevent, detect, treat and manage disease so that active and healthy ageing can be promoted. In this project, breakthrough research and radical innovation on new services for integrated care is achieved by means of an efficient and cost-effective service...

Funding Programme
Start Date
End Date
Total Funding
€ 3 433 219
European Countries Involved

Identification and modulation of pathogenic Amyloid beta-peptide species

AMYLOID

The frequency of Alzheimer's disease (AD) will dramatically increase in the ageing western society during the next decades. Currently, about 18 million people suffer worldwide from AD. Since no cure is available, this devastating disorder represents one of the most challenging socio-economical problems of our future. As onset and progression of AD...

Funding Programme
Start Date
End Date
Total Funding
€ 2 497 020
European Countries Involved

Identification and validation of cerebral KCa3.1/KCa2.3 potassium channels a drug tragets for the prevention and treatment of cerebral ischemia associated with diabetes and Alzheimers disease

BRAINIK

The objectives of the project are to identify and evaluate potassium channels of the KCa3.1/KCa2.X type as novel drug targets for the prevention and treatment of cerebrovascular ischemia and neuroprotection in metabolic disease and neurodegenerative disorders associated with vascular pathologies, as a new pathophysiological concept and treatment...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Identification and validation of human proteins that control tau seeding in cell-based and in vivo models

Tau Seeding

The microtubule-associated protein tau is the most commonly misfolded protein in neurodegenerative disorders including Alzheimer’s disease and other related tauopathies. These neurological illnesses are hypothesized to share a common mechanism of disease progression, where pathogenic aggregates or ‘seeds’ of the tau protein function as templates...

Funding Programme
Start Date
End Date
Total Funding
€ 171 461
European Countries Involved

Identification of personalized inflammatory profiles of aging and senescence which are modified specifically by risk factors of dementia modulating the predementia speed of symptomatic progression.

PREADAPT

Age represents by far the largest risk factor for dementia, including Alzheimer’s disease (AD) dementia. However, not every person will develop dementia during aging, indicating that age-related processes may not inescapably lead to dementia. The elucidation of the fundamental processes occurring in aging will likely offer new options to prevent or...

Funding Programme
Start Date
End Date
Total Funding
€ 2 400 000
European Countries Involved

Identification of the process by which patients recall and UPDATE their subjective RISK assessments for various diseases to incorporate objective genetic risk information

RISK-UPDATE

Project RISK-UPDATE will support the reintegration of Dr Talya Miron-Shatz, after four years spent as post-doctoral research collaborator with Nobel Laureate Prof. Daniel Kahneman at Princeton University, in the USA. Dr Miron-Shatz’s new host institution is Ono Academic College, Israel, which has agreed to set up a new research centre to facilitate...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Identifying and deciphering the mechanism of the cellular machinery responsible for disaggregation of intracellular prion-like Tau aggregates

REVERSING TAUOPATHY

Tauopathies are a group of neurodegenerative diseases, the most common of them being Alzheimer’s disease, which are associated with the aggregation of protein Tau in the brain. Despite major research efforts world-wide, the mechanism of Tau aggregation and its pathogenesis giving rise to such neurodegenerative diseases is not yet understood...

Funding Programme
Start Date
End Date
Total Funding
€ 171 461
European Countries Involved

Identifying and treating SORL1-associated Alzheimer’s disease

SORLA-FIX

The majority of the risk to develop Alzheimer's disease is influenced by genetic factors. We previously found that carrying a genetic mutation in the SORL1 gene can lead to a greatly increased chance of developing Alzheimer's Disease. SORL1 is involved in the production and processing of Alzheimer proteins that accumulate in the brain. e have...

Funding Programme
Start Date
End Date
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).